Form 4: Celcuity Inc. Director Richard E. Buller Reports Changes in Beneficial Ownership

Director Richard E. Buller reports changes in beneficial ownership of Celcuity Inc. stock and stock options, including transfers to a living trust.

Summary

• Richard E. Buller, a director of Celcuity Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities on April 8, 2024.
• The report indicates the transfer of stock options to a living trust, where Buller and his spouse are trustees and beneficiaries.
• Buller directly owns 8,081 shares of common stock, including 1,958 shares of restricted stock that will vest on April 30, 2024, or the date of the company's 2024 Annual Meeting of Stockholders.
• He also holds multiple stock options at exercise prices of $5.10, $5.50 and $9.58, some of which are directly owned and others held indirectly through the trust.
• The stock options have various expiration dates ranging from December 3, 2029, to May 17, 2032, and May 15, 2033.
• Some options are already 100% vested, while others will vest on April 30, 2024, or the date of the Company's 2024 Annual Meeting of Stockholders.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports transactions related to stock options and transfers to a trust, without indicating a strong positive or negative outlook.

Positives

• The director's continued beneficial ownership, even through a trust, suggests ongoing confidence in the company.
• The vesting of restricted stock and stock options incentivizes the director to contribute to the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's prospects.

Comparison to Industry Standards

• Monitoring insider transactions is a standard practice in corporate governance.
• Comparing the option exercise prices and vesting schedules to those of peer companies can provide insights into the competitiveness of Celcuity's compensation packages.
• Companies like Amgen, Biogen, and Gilead Sciences also have similar reporting requirements for their executives and directors.

Related Party Transactions

• The transfer of stock options to a living trust where the reporting person and his spouse are trustees and beneficiaries constitutes a related party transaction.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the director's holdings and transactions.
• The vesting of restricted stock and stock options aligns the director's interests with those of the shareholders.

Next Steps

• Monitor future filings for any further changes in beneficial ownership.
• Track the vesting of restricted stock on April 30, 2024, or the date of the Company's 2024 Annual Meeting of Stockholders.

Key Dates